⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
DIVISLAB - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.8
| Stock Code | DIVISLAB | Market Cap | 1,76,591 Cr. | Current Price | 6,651 ₹ | High / Low | 7,078 ₹ |
| Stock P/E | 68.6 | Book Value | 578 ₹ | Dividend Yield | 0.45 % | ROCE | 20.6 % |
| ROE | 15.6 % | Face Value | 2.00 ₹ | DMA 50 | 6,252 ₹ | DMA 200 | 6,224 ₹ |
| Chg in FII Hold | 0.21 % | Chg in DII Hold | -0.05 % | PAT Qtr | 653 Cr. | PAT Prev Qtr | 696 Cr. |
| RSI | 71.5 | MACD | 128 | Volume | 2,05,766 | Avg Vol 1Wk | 3,30,993 |
| Low price | 5,636 ₹ | High price | 7,078 ₹ | PEG Ratio | -7.46 | Debt to equity | 0.01 |
| 52w Index | 70.4 % | Qtr Profit Var | 9.88 % | EPS | 94.8 ₹ | Industry PE | 30.9 |
📊 Based on the given parameters, DIVISLAB shows strong fundamentals but is currently trading at a high valuation with elevated RSI (71.5), indicating overbought conditions. Intraday traders should be cautious as momentum is strong but profit-taking pressure may arise.
- 💰 Optimal Buy Price: Around 6,600 ₹ (near support from DMA 50)
- 📈 Profit-Taking Exit Levels: 6,720 ₹ – 6,780 ₹ (short-term resistance zone)
- 📉 Stop-Loss / Loss Protection: 6,540 ₹ (below intraday support)
- ⏱️ If Already Holding: Consider exiting if price fails to sustain above 6,700 ₹ or if RSI crosses 75 with declining volume.
Positive
- Strong ROCE (20.6%) and ROE (15.6%)
- Low debt-to-equity (0.01), virtually debt-free
- Consistent quarterly profit growth (Qtr Profit Var: 9.88%)
- FII holdings increased (+0.21%)
Limitation
- High P/E ratio (68.6) compared to industry average (30.9)
- RSI at 71.5 indicates overbought zone
- Volume lower than 1-week average, suggesting weaker participation
- PEG ratio negative (-7.46), showing valuation concerns
Company Negative News
- Quarterly PAT declined from 696 Cr. to 653 Cr.
- DII holdings slightly reduced (-0.05%)
Company Positive News
- Strong EPS (94.8 ₹) with consistent profitability
- Dividend yield of 0.45% adds shareholder value
- Stock trading near 52-week high (70.4% gain from low)
Industry
- Pharmaceutical industry P/E at 30.9, showing sector growth but DIVISLAB trades at a premium
- Global demand for pharma exports remains supportive
Conclusion
⚖️ DIVISLAB is fundamentally strong but currently overvalued for intraday trading. Momentum indicators suggest caution as RSI is high and volume participation is below average. Intraday traders may consider quick entries near 6,600 ₹ with tight stop-losses and exit around 6,720–6,780 ₹. If already holding, monitor momentum closely and exit if price weakens below 6,540 ₹.